Business · 11/06/2019
FDA Clears NIZORAL Topical Cream for Continued Sale
The US Food and Drug Administration has ruled that NIZORAL (ketoconazole) topical cream, 2%, was not withdrawn from sale due to safety or efficacy concerns, allowing the drug to remain on the market.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →